The evaluation of bone mineral density and risk factors of osteoporosis in patients with diffuse connective tissue diseases;Hodnocení denzity kostního minerálu a rizikových faktorů osteoporózy u nemocných se systémovými chorobami pojiva

Osteologicky Bulletin

Volumn 8, Issue 4, 2003, Pages 125-130

  Zurek M ^a   Horak P ^a   Pospisil Z ^a   Kraina, T ^a   Kusa L ^a   Scudla V ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Bone mineral density; Osteoporosis; Systemic lupus erythematosus; Systemic tissue diseases

Indexed keywords

GLUCOCORTICOID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BONE DENSITY; BONE MINERAL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OSTEOPENIA; OSTEOPOROSIS; POLYMYOSITIS; POSTMENOPAUSE; PREMENOPAUSE; RHEUMATOID ARTHRITIS; RISK FACTOR; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 1442355689     PISSN: 12113778     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Merrel M, Shulman LE. Determination of prognosis in chronic disease, illustrated by systemic lupus eryth-ematosus. J Chronic Dis 1955;1:12-32.
2. Abu-Shakra M, Urowitz MB, Gladman DD, et al. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 1995;22:1259-1264.
3. NE Lane, Q Rehman. Osteoporosis in the rheumatic disease patient. Lupus 2002;11:675-679.
4. Sonneveldt HA, van Leeuwen, Blom PS. Malabsorption in acrosclerosis. Disseminated scleroderma. Acta Med Scand. 1962;171:391-396.
5. Scudamore HH, Green PA, Hofman HN 2nd, et al. Scleroderma (progressive systemic sclerosis) of the small intestine with malabsorption. Evaluation of intestinal absorption and pancreatic function. Am J Gastroenterol. 1968;49:193-208.
6. Norimatsu H, Mori S, Kawanishi J, Kaji Y, Li J. Immobilization as the pathogenesis of osteoporosis: experimental and clinical studies. Osteoporos Int. 1997;7 Suppl 3:S57-62.
7. Caraballo PJ, Heit JA, Atkinson EJ, et al. Long-term use of oral anticoagulants and the risk of fracture. Arch Intern Med 1999;159:1750-1756.
8. Shefras J, Farquharson RG. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol 1996;65:171-174.
9. Kroger H, Honkanen R, Saarikoski S, et al. Decreased axial bone mineral density in perimenopausal women with rheumatoid arthritis - a population based study. Ann Rheum Dis. 1994;53:18-23.
10. Haugeberg G, Uhling T, Falch JA, et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum. 2000;43:2776-2784.
11. Eggelmeijer F, Papapoulos SE, Westedt ML, et al. Bone metabolism in rheumatoid arthritis; relation to disease activity. Br J Rheumatol 1993;32:87-91.
12. Formiga F, Moga I, Nolla JM, et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-276.
13. Bhattoa HP, Bettembuk P, Balogh A, et al. Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol. 2002;21:135-141.
14. Sinigaglia L, Varenna M, Binelli L, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol. 1999;26:1280-1284
15. La Montagna G, Vatti M, Valentini G, Tirri G. Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause. Clin Rheumatol. 1991;10:18-22.
16. Di Munno O, Mazzantini M, Massei P, et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol. 1995;14:407-412
17. Antelava OA, Smirnov AV, Demin NV, et al. Bone mineral density in idiopathic inflammatory myopathies. Klin Med. 2003;81:57-61.
18. Stewart WA, Acott PD, Salisbury SR, Lang BA. Bone mineral density in juvenile dermatomyositis: assessment using dual x-ray absorptiometry. Arthritis Rheum. 2003;48:2294-2298.
19. Pavelka K, Zitko T, Vencovský J, et. al. Glukokortikoidy indukovaná osteporosa u nemocných se systémovým onemocněním pojiva - vliv vysokých dávek korti-koidů (abstrakt). Osteol bulletin 2003;8:98.
20. Kanis JA, Melton LJ 3rd, Christiansen C, et al. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-1141.
21. Dhillon VB, Davies MC, Hall ML, et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry. Ann Rheum Dis 1990;49:624-626.
22. Pons F, Peris P, Guanabens N, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 1995;34:742-776.
23. Li EK, Tam LS, Young RP, et al. Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol. 1998;37:405-410.
24. Young RP, Lau EMC, Birjandi Z, et al. Interethnic differences in hip fracture rate and the Vitamin D receptor polymorphism. Lancet 1996;348:688-689.
25. Toyoda T, Inokuchi S, Saito S, et al. Bone loss of the radius in rheumatoid arthritis. Comparison between 34 patients and 40 controls. Acta Orthop Scand. 1996 Jun;67:269-273.
26. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol. 2001;28:102-108.
27. Becker A, Fischer R, Scherbaum WA, Schneider M. Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus. 2001;10:809-814.
28. Kvien TK, Haugeberg G, Uhlig T, et al. Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis. Ann Rheum Dis. 2000;59:805-811.
29. Coimbra IB, Costallat LT. Bone mineral density in systemic lupus erythematosus and its relation to age at disease onset, plasmatic estradiol and immunosuppressive therapy. Joint Bone Spine. 2003;70:40-45.
30. Gilboe IM, Kvien TK, Haugeberg G, Husby G. Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis. 2000 Feb;59:110-115.